The cardioprotective effects of paroxetine in CH, as well as its effect in mitigating associated hypertension and myocardial infarction, through the inhibition of GRK2 activity, have also been demonstrated [28]. The gene discussed is GRK2; the disease is cyclic hematopoiesis.